Variables | Overall | Non-PPM | Moderate PPM | *p value |
---|---|---|---|---|
(n = 106) | (n = 58) | (n = 45) | ||
Age, years | 52.5 ± 8.6 | 52.1 ± 10.2 | 53.0 ± 12.7 | 0.398 |
Age group, years | ||||
≤ 65 | 56(52.8%) | 30(51.7%) | 25(55.6%) | 0.831 |
> 65 | 50(47.2%) | 28(48.3%) | 20(44.4%) | 0.815 |
Female sex | 79 (74.5%) | 53 (91.4%) | 23 (51.1%) | 0.047 |
Height (m) | 1.65 ± 0.09 | 1.62 ± 0.05 | 1.69 ± 0.04 | 0.106 |
Body surface area (m2) | 1.56 ± 0.16 | 1.48 ± 0.09 | 1.66 ± 0.16 | 0.038 |
Projected EOAI (cm2/m2) | 0.90 ± 0.04 | 0.95 ± 0.03 | 0.84 ± 0.02 | 0.041 |
Body mass index (kg/ m2) | 22.9 ± 2.8 | 22.1 ± 1.1 | 22.9 ± 2.7 | 0.109 |
Pre-NYHA class | ||||
I/II | 52(49.1%) | 35(60.3%) | 16(35.6%) | 0.097 |
III/IV | 54 (50.9%) | 23(39.7%) | 29(64.4%) | 0.105 |
Ejection fraction | ||||
≥50% | 45(44.3%) | 30(51.7%) | 15(33.3%) | 0.159 |
<50% | 58(55.7%) | 28(48.3%) | 30(66.7%) | 0.207 |
Atrial fibrillation | 15 (14.2%) | 9 (15.5%) | 4(8.9%) | 0.281 |
Chronic heart failure | 13(12.3%) | 5(8.6%) | 8(17.8%) | 0.178 |
Ischemic heart disease | 37(19.8%) | 21(36.2%) | 13(28.9%) | 0.362 |
Renal insufficiency | 8(7.5%) | 5(8.6%) | 3(6.7%) | 0.518 |
Hypertension | 36 (34.0%) | 21(36.2%) | 15(33.3%) | 0.496 |
Diabetes | 29 (27.3%) | 10(17.2%) | 16(35.6%) | 0.079 |
Valve pathology | ||||
Degenerative | 33 (31.1%) | 18 (31.0%) | 14(31.1%) | 0.557 |
Rheumatic | 53 (50.0%) | 27 (46.6%) | 25(55.6%) | 0.364 |
Infective | 3 (2.8%) | 2(3.4%) | 1(2.2%) | 0.599 |
CPB time (min) | 108 ± 32 | 105 ± 21 | 110 ± 35 | 0.541 |
Cross-clamp time (min) | 90 ± 23 | 87 ± 18 | 92 ± 27 | 0.617 |
In-hospital death | 3(2.8%) | - | - | - |